Factores de riesgo en el tratamiento de la fototerapia en pacientes neonatos con hiperbilirrubinemia, Hospital General IESS Babahoyo diciembre 2022- mayo 2023.
Neonatal hyperbilirubinemia presents as a yellowish coloration of the skin and mucous membranes, reflecting a temporary alteration between the elimination and production of bilirubin. There are multiple causes of neonatal jaundice, being a frequent problem around the world. The complications that we...
Zapisane w:
| 1. autor: | |
|---|---|
| Kolejni autorzy: | |
| Format: | bachelorThesis |
| Wydane: |
2023
|
| Hasła przedmiotowe: | |
| Dostęp online: | http://dspace.utb.edu.ec/handle/49000/14311 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
| Streszczenie: | Neonatal hyperbilirubinemia presents as a yellowish coloration of the skin and mucous membranes, reflecting a temporary alteration between the elimination and production of bilirubin. There are multiple causes of neonatal jaundice, being a frequent problem around the world. The complications that we are most interested in avoiding are changes in the newborn's nervous system, kernicterus, as well as hearing changes, since they leave serious and disabling sequelae. Phototherapy is one of the most effective treatments for the control of neonatal jaundice, it consists of exposing the newborn to a fluorescent light source. Nurses must be trained in the use of Phototherapy in neonates since they demand a lot of care. In the present investigation it was established to determine the risk factors in the treatment of phototherapy in neonatal patients with hyperbilirubinemia at the General Hospital Iess Babahoyo period December 2022-May 2023. A descriptive cross-sectional study was developed, where the techniques and instrument The study will be carried out through the review and documentary analysis of the medical records. The study population was made up of 95 patients admitted to the NICU unit of the Iess Babahoyo General Hospital during the period from December 2022 to May 2023. The results obtained allowed us to determine that the risk factors are gestational age, birth weight and incompatibility. ABO, phototherapy being the treatment of choice since it indicates a high percentage of effectiveness. |
|---|